Sharecare, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 7 months to Dec 31, 2020
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash (used in) operating activities:
Interest income from investments held in trust account
Depreciation and amortization expense
Non-cash interest expense
Write-off of deferred financing fees and debt discount
Loss on extinguishment of debt
Amortization of contract liabilities
Accretion of contract liabilities
Lease right-of-use asset expense
Loss from equity method investment
Amortization of non-cash payment for research and development
Change in fair value of warrant liability and contingent consideration
Share-based compensation
Deferred income taxes
Payment of PIK interest
Other
Changes in operating assets and liabilities:
Prepaid expenses
Accounts receivable, net and other receivables
Prepaid expenses and other assets
Accounts payable and accrued expense
Operating lease liabilities
Deferred revenue

Net cash used in operating activities
Cash flows from investing activities:
Principal deposited in Trust Account
Acquisition of CareLinx
Acquisition of MindSciences
Acquisition of doc.ai
Purchases of property and equipment
Capitalized internal-use software costs
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from sale of units in initial public offering
Payment of underwriters’ discount
Payment of offering costs
Advances received from Promissory note
Repayment of advances received from Promissory note
Proceeds from issuance of redeemable convertible preferred stock and warrants, net of issuance costs
Proceeds from issuance of debt
Repayment of debt
Proceeds from exercise of common stock options
Repurchased shares of common stock related to exercise of employee stock options
Payments for shares repurchased
Payments on financing lease obligations
Financing costs
Net cash (used in) provided by financing activities

Increase in cash during period
Effect of exchange rates on cash and cash equivalents
Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of cash flow information:
Deferred underwriting compensation
Class A common stock subject to possible redemption
Changes in value of common stock subjection to redemption
Offering costs paid by sponsor in exchange for founder shares
Cash paid for interest
Cash paid for income taxes

Noncash financing activities:
CareLinx working capital adjustment
Deferred offering costs not yet paid

Comments